V Dirix1, F Vermeulen, F Mascart. 1. Laboratory of Vaccinology and Mucosal Immunity, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Abstract
PURPOSE: To characterize the maturation of CD4(+) regulatory T lymphocytes (Treg) and of cytokine productions in preterm infants during their first 16 months of life. METHODS: The proportions of CD4(+) Treg cells, their phenotypic characteristics, and the mitogen-induced cytokine productions by peripheral blood mononuclear cells (PBMC) were analysed in 26 very-preterm infants from 2 to 16 months of age, and compared to results obtained for 17 cord blood mononuclear cells (CBMC) from very-preterm infants, 12 from term infants and to blood samples from 40 adults. RESULTS: High proportion of CD25(+/high)CD4(+) Treg cells was found at birth in preterm CB with a gradual decreased afterwards. However, their percentage at 16 months of age was still higher than in term CB. In contrast to adults, preterm infants were characterized by excellent linear correlations between the proportions of CD25(+/high)CD4(+) and CD25(+/high)FoxP3(+) CD4(+) or CD25(+/high)CD127(low) CD4(+) or CD25(+/high)FoxP3(+)CD127(low) CD4(+)T lymphocytes. CD45RO(+) and HLA-DR(+) expressions were very low on preterm Treg and progressively increased with age. Functionally, preterm compared to term CBMC secreted in response to phytohaemagglutinin lower IFN-γ, higher IL-5 and similar IL-12p70, IL-10, IL-2 and IL-13 concentrations. IFN-γ, IL-12p70 and IL-10 productions were at 16 months still lower than those obtained for adults CONCLUSION: Preterm differed from term CBMC both by their proportion and phenotype of CD4(+) Treg lymphocytes and by their cytokine secretions. Maturation occurred during infancy with similar IFN-γ secretion but with persistently higher proportion of CD4(+) Treg cells in 1 year preterm infants compared to term neonates.
PURPOSE: To characterize the maturation of CD4(+) regulatory T lymphocytes (Treg) and of cytokine productions in preterm infants during their first 16 months of life. METHODS: The proportions of CD4(+) Treg cells, their phenotypic characteristics, and the mitogen-induced cytokine productions by peripheral blood mononuclear cells (PBMC) were analysed in 26 very-preterm infants from 2 to 16 months of age, and compared to results obtained for 17 cord blood mononuclear cells (CBMC) from very-preterm infants, 12 from term infants and to blood samples from 40 adults. RESULTS: High proportion of CD25(+/high)CD4(+) Treg cells was found at birth in preterm CB with a gradual decreased afterwards. However, their percentage at 16 months of age was still higher than in term CB. In contrast to adults, preterm infants were characterized by excellent linear correlations between the proportions of CD25(+/high)CD4(+) and CD25(+/high)FoxP3(+) CD4(+) or CD25(+/high)CD127(low) CD4(+) or CD25(+/high)FoxP3(+)CD127(low) CD4(+)T lymphocytes. CD45RO(+) and HLA-DR(+) expressions were very low on preterm Treg and progressively increased with age. Functionally, preterm compared to term CBMC secreted in response to phytohaemagglutinin lower IFN-γ, higher IL-5 and similar IL-12p70, IL-10, IL-2 and IL-13 concentrations. IFN-γ, IL-12p70 and IL-10 productions were at 16 months still lower than those obtained for adults CONCLUSION: Preterm differed from term CBMC both by their proportion and phenotype of CD4(+) Treg lymphocytes and by their cytokine secretions. Maturation occurred during infancy with similar IFN-γ secretion but with persistently higher proportion of CD4(+) Treg cells in 1 year preterm infants compared to term neonates.
Authors: Kajsa Wing; Pia Larsson; Kerstin Sandström; Samuel B Lundin; Elisabeth Suri-Payer; Anna Rudin Journal: Immunology Date: 2005-08 Impact factor: 7.397
Authors: Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone Journal: J Exp Med Date: 2006-07-03 Impact factor: 14.307
Authors: J Pagel; A Hartz; J Figge; C Gille; S Eschweiler; K Petersen; L Schreiter; J Hammer; C M Karsten; D Friedrich; E Herting; W Göpel; J Rupp; C Härtel Journal: Clin Exp Immunol Date: 2016-06-12 Impact factor: 4.330
Authors: Cesar M Rueda; Maria E Moreno-Fernandez; Courtney M Jackson; Suhas G Kallapur; Alan H Jobe; Claire A Chougnet Journal: Eur J Immunol Date: 2015-06-25 Impact factor: 5.532
Authors: Kristin M Scheible; Jason Emo; Nathan Laniewski; Andrea M Baran; Derick R Peterson; Jeanne Holden-Wiltse; Sanjukta Bandyopadhyay; Andrew G Straw; Heidie Huyck; John M Ashton; Kelly Schooping Tripi; Karan Arul; Elizabeth Werner; Tanya Scalise; Deanna Maffett; Mary Caserta; Rita M Ryan; Anne Marie Reynolds; Clement L Ren; David J Topham; Thomas J Mariani; Gloria S Pryhuber Journal: JCI Insight Date: 2018-02-22
Authors: Cesar M Rueda; Casey B Wells; Tate Gisslen; Alan H Jobe; Suhas G Kallapur; Claire A Chougnet Journal: Hum Immunol Date: 2014-11-08 Impact factor: 2.850
Authors: Ravi Misra; Syed Shah; Deborah Fowell; Hongyue Wang; Kristin Scheible; Sara Misra; Heidie Huyck; Claire Wyman; Rita M Ryan; Anne Marie Reynolds; Tom Mariani; Philip J Katzman; Gloria S Pryhuber Journal: Hum Immunol Date: 2015-03-20 Impact factor: 2.850
Authors: Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray Journal: J Immunol Date: 2021-11-24 Impact factor: 5.422
Authors: Jessica G Lee; Kathleen E Jaeger; Yoichi Seki; Yi Wei Lim; Christina Cunha; Aleksandra Vuchkovska; Alexander J Nelson; Anya Nikolai; Dan Kim; Michael Nishimura; Katherine L Knight; Paula White; Makio Iwashima Journal: Immunology Date: 2021-03-07 Impact factor: 7.215